Mua, Aljanor .

HRN: 24-41-26  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2025
CEFUROXIME 750MG (VIAL)
11/25/2025
12/03/2025
IV
400mg
Q8H
Prophylaxis For Surgery
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: